Showing results (301-310 of 582) with videos related to

Sort By:
Pageof 59
Chemmedchem|July 30, 2013
Identification of the binding site of an allosteric ligand using STD-NMR, docking, and CORCEMA-ST calculationsWei Zhang, Rongbao Li, Ronald Shin, et al.
Indian Journal of Anaesthesia|November 28, 2022
Dynamometer based hand grip strength as a clinical tool for objective assessment of post-operative residual muscle weaknessCh Rama Krishna Prasad, A Chaitanya Pratyusha, Chaganti Sharmila, et al.
Biomedical Microdevices|November 20, 2016
An ultrasensitive label free nanobiosensor platform for the detection of cardiac biomarkersDurga Prakash Matta, Suryasnata Tripathy, Siva Rama Krishna Vanjari, et al.
Indian Journal of Anaesthesia|March 27, 2023
Recent advances in system management, decision support systems, artificial intelligence and computing in anaesthesiaBhavna Gupta, Nishant Sahay, Krishnagopal Vinod, et al.
Analytical Biochemistry|October 9, 2020
High resolution and high throughput analytical methods for d-tagatose and process related impurities using capillary electrophoresisSri Rama Krishna Surapureddi, Kunta Ravindhranath, Ghantasala S Sameer Kumar, et al.
The Journal of Organic Chemistry|February 21, 2022
Ready Access to Benzannulated [5,5]-Oxaspirolactones Using Au(III)-Catalyzed Cascade CyclizationsYash Mankad, Sagar S Thorat, Pronay Das, et al.
Biosensors & Bioelectronics|September 17, 2023
Toll-like receptor-immobilized carbon paste electrodes with plasma functionalized amine termination: Towards real-time electrochemical based triaging of gram-negative bacteriaRahul Gangwar, Debjyoti Ray, Sajmina Khatun, et al.
Luminescence : the Journal of Biological and Chemical Luminescence|April 29, 2014
Synthesis and spectral investigations of Cu(II) ion-doped NaCaAlPO4 F3 phosphorV Pushpa Manjari, Ch Rama Krishna, Ch Venkata Reddy, et al.
Plos One|November 3, 2011
Differential sensitivity of ERBB2 kinase domain mutations towards lapatinibRama Krishna Kancha, Nikolas von Bubnoff, Natalie Bartosch, et al.
Haematologica|August 30, 2008
Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutationRama Krishna Kancha, Nikolas von Bubnoff, Cornelius Miething, et al.
Pageof 59